Name of the research study
Lead researcher(s) name(s)
University, clinic, or research body
e.g., Phase I, II, III, observational, qualitative, etc.
e.g., Psilocybin for depression, MDMA for PTSD, Ayahuasca, Ketamine, etc.
PAT model used: e.g., IFS, somatic, CBT, traditional ceremony
e.g., Veterans, LGBTQ+, First Nations, treatment-resistant depression
Inclusion/exclusion summary
Committee, approval number (if applicable)
Grant provider or sponsor (if applicable)
(e.g., trauma, neurodiversity, psilocybin, integration)
